SecBot SecBot
PRESS-RELEASE ·Filed Aug 13, 2026

TIL

Instil Bio, Inc.
NEUTRAL
Impact 4/10
Horizonmonths Processed3mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Monitor for any announcement of a potential acquisition or in-licensing deal, as the company's stated strategy and cash position suggest a transaction is the primary catalyst. Absent a deal, the stock is likely to trade on cash runway and expense management alone.

DirectionNeutral
Confidencehigh
Horizonmonths

Price Chart

Loading chart...

Executive Summary

Instil Bio reported Q2 2026 GAAP net loss of $0.63 per share, narrowing from a $3.24 loss in Q2 2025, driven by sharply lower operating expenses as the company maintains a lean cash-burn structure while evaluating acquisition and in-licensing opportunities. Cash and marketable securities stood at $69.9M, down from $76.3M at year-end 2025, but management expects this to fund operations beyond 2027. The filing is routine for a pre-revenue biotech with no pipeline catalysts, the stock's direction hinges entirely on whether a transaction materializes, not on the quarterly loss trajectory.

Key Financial Metrics

EPS
−$0.63
est −$0.35 · -80.0%
Rating
in line

Key Facts

  • GAAP net loss per share of $0.63 for Q2 2026 vs $3.24 in Q2 2025
  • Cash, cash equivalents, restricted cash and marketable securities of $69.9M as of June 30, 2026
  • Management expects cash runway beyond 2027
  • In-process R&D expenses were nil vs $10.0M in Q2 2025
  • Company is evaluating potential acquisitions, in-licensing and related opportunities

Financial Impact

GAAP net loss narrowed to $4.3M from $21.4M year-over-year; cash burn of ~$6.4M in H1 2026

net losscash positionoperating expenses

Risk Factors

  • No pipeline or clinical-stage assets generating value
  • Cash burn continues with no revenue; any transaction may be dilutive or fail to materialize

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
71% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3345000

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026